A phase II study of the efficacy, safety, and determinants of response to 5-azacitidine (Vidaza®) in patients with chronic myelomonocytic leukemia. Issue 10 (2nd October 2016)

Record Type:: Journal Article
Title:: A phase II study of the efficacy, safety, and determinants of response to 5-azacitidine (Vidaza®) in patients with chronic myelomonocytic leukemia. Issue 10 (2nd October 2016)
Main Title:: A phase II study of the efficacy, safety, and determinants of response to 5-azacitidine (Vidaza®) in patients with chronic myelomonocytic leukemia
Authors:: Tantravahi, Srinivas K.
Szankasi, Philippe
Khorashad, Jamshid S.
Dao, Kim-Hien
Kovacsovics, Tibor
Kelley, Todd W.
Deininger, Michael W.
Abstract:
Is Part Of:: Leukemia & lymphoma. Volume 57:Issue 10(2016:Oct.)
Journal:: Leukemia & lymphoma
Issue:: Volume 57:Issue 10(2016:Oct.)
Issue Display:: Volume 57, Issue 10 (2016)
Year:: 2016
Volume:: 57
Issue:: 10
Issue Sort Value:: 2016-0057-0010-0000
Page Start:: 2441
Page End:: 2444
Publication Date:: 2016-10-02
Subjects:: Leukemia -- Periodicals
Lymphomas -- Periodicals
616.99419
Journal URLs:: http://informahealthcare.com ↗
DOI:: 10.3109/10428194.2016.1138295 ↗
Languages:: English
ISSNs:: 1042-8194
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5185.251500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 353.xml